Sage Therapeutics
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 10
- Market Cap
- $495.1M
- Website
- http://www.sagerx.com
- Introduction
Sage Potash Corp is engaged in the acquisition, exploration, and development of mineral properties. Its principal business activity is the acquisition, exploration, and development of potash mineral properties. It holds interest in Sage Plain Potash property. The projects of the company include Sage Potash and Sage Lithium.
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
- First Posted Date
- 2021-09-20
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 22
- Registration Number
- NCT05049343
- Locations
- 🇺🇸
Sage Investigational Site, Newark, New Jersey, United States
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
- Conditions
- Interventions
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 26
- Registration Number
- NCT04602624
- Locations
- 🇺🇸
Sage Investigational Site, North Canton, Ohio, United States
A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)
- Conditions
- Interventions
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 29
- Registration Number
- NCT04537806
- Locations
- 🇺🇸
Sage Investigational Site, Seattle, Washington, United States
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 18
- Registration Number
- NCT04476017
- Locations
- 🇺🇸
Sage Investigational Site, Chicago, Illinois, United States
A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor
- First Posted Date
- 2020-03-12
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 69
- Registration Number
- NCT04305275
- Locations
- 🇺🇸
Sage Investigational Site, Huntington, West Virginia, United States
A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)
- First Posted Date
- 2020-02-18
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- Sage Therapeutics
- Registration Number
- NCT04273191
Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression
- Conditions
- First Posted Date
- 2019-04-23
- Last Posted Date
- 2019-06-28
- Lead Sponsor
- Sage Therapeutics
- Registration Number
- NCT03924492
A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 40
- Registration Number
- NCT03844906
- Locations
- 🇺🇸
Sage Investigational Site, Berlin, New Jersey, United States
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 6
- Registration Number
- NCT03787758
- Locations
- 🇺🇸
Sage Investigational Site, Marlton, New Jersey, United States
A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
- First Posted Date
- 2018-12-11
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Sage Therapeutics
- Target Recruit Count
- 22
- Registration Number
- NCT03771586
- Locations
- 🇺🇸
Sage Investigational Site, Berlin, New Jersey, United States